Sica Fletcher

MAY 8, 2020

Sica | Fletcher believes Brown & Brown is the publicly traded company that is most comparable to private, middle market U.S. In Q1 2020, Brown & Brown operated at a 34.6% For owners and executives of private insurance brokers, Brown & Brown's first quarter earnings call provides a treasure trove of information.

Insurance 52

Insurance Retail Debt Broker 52

Transactional Delights

NOVEMBER 24, 2020

Following the November 2019 signing, covid hit and LVMH announced that it would not be able to close the deal by the agreement’s drop-dead date of November 24, 2020 [2] after the French Government sent a letter [3] to LVMH directing it to pause the deal until 2021. On Friday, October 25, the day before the leak TIF was trading at $98.55.

M&A 40

M&A Mergers and Acquisitions IT Shares 40

Software Equity Group

FEBRUARY 28, 2023

Stock prices and valuations of many leading public SaaS companies have fallen drastically from the beginning of 2022—but while that will affect the private market, it does not necessarily spell doom and gloom. This post will examine the current state of public SaaS company valuations and what it means for private companies.

Valuation 52

Valuation M&A Stock Profitability 52

Focus Investment Banking

JUNE 13, 2023

This Australian oncology platform, backed by PE giant KKR, acquired 21st Century Oncology in May 2020 in a deal valued at over $1 billion. Formerly owned by Tahoe Investment Group, which bought the company in April 2017, Alliance was acquired by Akumin, a publicly traded company, in June 2021 for $820 million. Alliance Health Services.

Hospitality 52

Hospitality Private Equity Healthcare Medical 52

Cooley M&A

JULY 9, 2021

However, the court’s January 2020 decision in the Panera appraisal proceeding provides a cautionary tale about the downside of prepaying the deal price for appraisal shares. Panera Bread was a publicly traded company that JAB Holdings B.V. took private in 2017 for $315/share. Contributors. Barbara Borden. Caitlin Gibson.

Mergers and Acquisitions 52

Mergers and Acquisitions Sale Shares Entertainment 52

Cooley M&A

JANUARY 22, 2020

If, however, capital markets and the economy weaken in 2020, M&A transactions may be the only viable option for life sciences companies to access capital, in which case we would expect to see more M&A transactions by number, but they would likely be paired with lower purchase prices and/or more highly structured. Contributors.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

Cooley M&A

MARCH 2, 2021

A SPAC is a publicly traded shell company with no underlying operating business that seeks to merge with a target operating company. According to Nasdaq , in 2015, SPACs made up approximately 12% of the IPO market, but by 2020, that number had risen to approximately 53%. Special purpose acquisition companies (SPACs) are on the rise.

Securities 40

Securities IPO Mergers and Acquisitions Shares 40

Intrepid Banker Insights

MARCH 28, 2023

For example, businesses who took advantage of the “cheap money” from the Main Street Lending Program in 2020 are now past the two-year principal payment holiday and must ensure they can service the 15-percent annual amortization along with the higher-cost interest payments.

Capital 52

Capital Advisory Bank Banking 52

Wall Street Mojo

FEBRUARY 9, 2024

When listed as publicly traded companies, they mostly become small-cap and micro-cap stocks trading on the exchange. The company raised its first credit fund in October 2020 at $135 million. The classification helps investors gauge the performance and growth potential to make future investments.

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. There are, however, reasons to think that M&A in the life sciences industry is on the upswing.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

OCTOBER 29, 2020

As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). A distinct feature of SPAC 3.0 is the increased frequency at which SPAC IPOs are occurring. Revisiting Governance Documentation.

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

Cooley M&A

SEPTEMBER 16, 2022

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. Vote-down termination fee (i.e.,

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

JANUARY 20, 2022

Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. A healthy 90 biopharma M&A transactions were announced in 2021 (compared to 69 in 2020 and 70 in 2019, the most transactions since 2016). As we noted in our 2020 year?end

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40